Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months - News-Medical.Net

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

The binding responses and temporal dynamics of antibodies elicited against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to vaccination must be fully understood to design futur… [+5626 chars]

full article...